CHE Chemed Corporation

Chemed To Report First-Quarter 2020 Earnings April 28, Related Conference Call To Be Held On April 29

CINCINNATI--(BUSINESS WIRE)--

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2020, on Tuesday, April 28, 2020, following the close of trading on the New York Stock Exchange.

Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, April 29, 2020, to discuss the company's quarterly results and to provide an update on its business.

The toll-free dial-in number for the conference call is 844-743-2500 for U.S. and Canadian participants and for international participants. The participant Conference ID is 2398574. A live webcast of the call can be accessed on Chemed's website at by clicking on Investor Relations Home.

A taped replay of the conference call will be available beginning approximately two hours after the call's conclusion. It can be accessed by dialing toll-free 855-859-2056 for U.S. and Canadian callers and for international callers and will be available for one week following the live call. The replay Conference ID is 2398574. An archived webcast will also be available at .

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation () operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.

Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

EN
16/04/2020

Underlying

CHEChemed Corporation

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Chemed Corporation

Free Trial
CHE Chemed Corporat...

Chemed Corp: 1 director

A director at Chemed Corp sold 1,500 shares at 577.860USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

CHE CHEMED CORPORATION
05/08/25 May 8, 2025 1 EN
 PRESS RELEASE
Free
CHE Chemed Corporat...

Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcar...

CINCINNATI--(BUSINESS WIRE)-- Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 35th Annual Healthcare Conference on Monday, March 17, 2025, at approximately 9:20 a.m. (ET). The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corpor...

March 3, 2025 1 EN
 PRESS RELEASE
Free
CHE Chemed Corporat...

Chemed Reports Fourth-Quarter 2024 Results

CINCINNATI--(BUSINESS WIRE)-- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, to provide additional cont...

February 26, 2025 1 EN
 PRESS RELEASE
Free
CHE Chemed Corporat...

Chemed Corporation Declares Quarterly Dividend of 50 Cents

CINCINNATI--(BUSINESS WIRE)-- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on March 14, 2025, to shareholders of record as of February 24, 2025. This is equal to the dividend paid in December 2024. This represents the 215th consecutive quarterly dividend paid by Chemed in its 53 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation () operates two wholly owned subsidiaries: VITAS Healthcare and R...

February 14, 2025 1 EN
 PRESS RELEASE
Free
CHE Chemed Corporat...

Chemed To Report Fourth-Quarter 2024 Earnings February 26, Related Con...

CINCINNATI--(BUSINESS WIRE)-- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2024, on Wednesday, February 26, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 27, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed’s website, or the hosting website . Partic...

February 11, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch